Fig.2From: Changes in the BTK/NF-κB signaling pathway and related cytokines in different stages of neuromyelitis optica spectrum disordersBTK, PI3K, IKK, NF-κB CXCL2, and CXCL12 mRNA levels in the NMOSD group. mRNA expression of BTK, PI3K, IKK, NF-κB and CXCL2, CXCL12 in the acute and remission groups (A–F). ★p < 0.05 vs. Vehicle group; ★p < 0.05 vs. remission groupBack to article page